Jodie Low

Jodie Low, Vice President of Government Affairs & Policy, has been with the firm for over five years and maintains strong relationships with legislative staff on the House Energy & Commerce and Ways & Means Committees, as well as Senate Health, Education, Labor & Pensions (HELP) and Finance Committees. In the 108th, 109th and 110th Congresses, Ms. Low lobbied on a number of medical device, biotechnology, and pharmaceutical issues, including the Food and Drug Administration Amendments Act (FDAAA), the Medicare, Medicaid and SCHIP Extension Act, the Deficit Reduction Act (DRA), the Medical Device User Fee Modernization Act, the Medicare Modernization Act, the Kidney Care Quality Improvement Act, the Screening Abdominal Aortic Aneurysm Very Efficiently (SAAAVE) Act, the Access to Better Choice in Dialysis (ABCD) Act, and the U.S. Patent and Trademark Fee Modernization Act, among others. Ms. Low served as Executive Director of the Coalition for Dialysis Patient Choice from 2005 to 2007. In this capacity she managed all federal activity for the Coalition including submitting hearing testimony, identifying sponsors and co-sponsors for legislation, and representing the Coalition in meetings with Members of Congress and their staff, as well as policy-makers within the Administration. Ms. Low previously worked in corporate communications for Healthcare Realty Trust, a Real Estate Investment Trust (REIT) in Nashville, TN. Ms. Low previously worked in corporate communications for Healthcare Realty Trust, a Real Estate Investment Trust (REIT) in Nashville, TN. She received her Bachelor of Science, Summa Cum Laude from Vanderbilt University with concentrations in Economics and Mathematics. She is currently seeking her Master in Public Health in Health Policy at George Washington University.